{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:25:31Z","timestamp":1777339531880,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd010008.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000}}],"reference-count":31,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010008.pub5","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T08:19:48Z","timestamp":1637914788000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Topiramate for juvenile myoclonic epilepsy"],"prefix":"10.1002","volume":"2021","author":[{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology; Beijing Tiantan Hospital, Capital Medical University; 100070 Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Jun","family":"Tai","sequence":"additional","affiliation":[{"name":"Department of Neurology; Jiaozhou Hospital Affiliated to Dongfang Hospital; Shangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Neurology; Chinese PLA General Hospital; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD010008.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archneur.62.11.1705","article-title":"Topiramate in patients with juvenile myoclonic epilepsy","volume":"62","author":"Biton","year":"2005","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010008.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.yebeh.2007.03.003","article-title":"Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison","volume":"10","author":"Levisohn","year":"2007","journal-title":"Epilepsy & Behavior"},{"issue":"8","key":"10.1002\/14651858.CD010008.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jocn.2012.10.020","article-title":"A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy","volume":"20","author":"Park","year":"2013","journal-title":"Journal of Clinical Neuroscience"},{"issue":"3B","key":"10.1002\/14651858.CD010008.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1590\/S0004-282X2005000500001","article-title":"Topiramate for the treatment of juvenile myoclonic epilepsy","volume":"63","author":"Sousa Pda","year":"2005","journal-title":"Arquivos de Neuro-psiquiatria"},{"issue":"4B","key":"10.1002\/14651858.CD010008.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1590\/S0004-282X2007000700036","article-title":"Juvenile myoclonic epilepsy","volume":"65","author":"Alfradique","year":"2007","journal-title":"Arquivos de Neuro-psiquiatria"},{"issue":"7","key":"10.1002\/14651858.CD010008.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.52.7.1330","article-title":"A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures","volume":"52","author":"Biton","year":"1999","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010008.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1059-1311(00)90530-2","article-title":"Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate","volume":"10","author":"Calleja","year":"2001","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD010008.pub5-BIB0008|cit8","unstructured":"Deeks JJ Higgins JPT Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"1","key":"10.1002\/14651858.CD010008.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD010008.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0404.2002.02071.x","article-title":"Low-dose topiramate in adults with treatment-resistant partial-onset seizures","volume":"106","author":"Guberman","year":"2002","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD010008.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-8993(98)00116-4","article-title":"Suppression by topiramate of epileptiform burst discharges in hippocampal CA3 neurons of spontaneously epileptic rat in vitro","volume":"789","author":"Hanaya","year":"1998","journal-title":"Brain Research"},{"issue":"7414","key":"10.1002\/14651858.CD010008.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010008.pub5-BIB0013|cit13","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD010008.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1528-1167.2005.00309.x","article-title":"Epidemiology of idiopathic generalized epilepsies","volume":"46","author":"Jallon","year":"2005","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD010008.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0404.1985.tb00900.x","article-title":"Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy)","volume":"72","author":"Janz","year":"1985","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD010008.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010008.pub5-BIB0017|cit17","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD010008.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1528-1167.2009.02230.x","article-title":"The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?","volume":"50","author":"Montouris","year":"2009","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD010008.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1528-1157.1991.tb04708.x","article-title":"Juvenile myoclonic epilepsy: factors of error involved in the diagnosis and treatment","volume":"32","author":"Panayiotopoulos","year":"1991","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD010008.pub5-BIB0020|cit20","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"9","key":"10.1002\/14651858.CD010008.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010008.pub5-BIB0022|cit22","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD010008.pub5-BIB0023|cit23","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"3","key":"10.1002\/14651858.CD010008.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40263-018-00602-2","article-title":"Treatment of juvenile myoclonic epilepsy in patients of child-bearing potential","volume":"33","author":"Serafini","year":"2019","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1002\/14651858.CD010008.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.seizure.2007.07.001","article-title":"Levetiracetam monotherapy in juvenile myoclonic epilepsy","volume":"17","author":"Sharpe","year":"2008","journal-title":"Seizure"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010008.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1528-1157.2000.tb02165.x","article-title":"Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism","volume":"41","author":"White","year":"2000","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD010008.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(97)00543-0","article-title":"Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells","volume":"231","author":"Zona","year":"1997","journal-title":"Neuroscience Letters"},{"issue":"8","key":"10.1002\/14651858.CD010008.pub5-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010008","article-title":"Topiramate monotherapy for juvenile myoclonic epilepsy","author":"Liu","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD010008.pub5-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010008.pub2","article-title":"Topiramate monotherapy for juvenile myoclonic epilepsy","author":"Liu","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010008.pub5-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010008.pub3","article-title":"Topiramate monotherapy for juvenile myoclonic epilepsy","author":"Liu","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010008.pub5-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010008.pub4","article-title":"Topiramate for juvenile myoclonic epilepsy","author":"Liu","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:52:45Z","timestamp":1689688365000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010008.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010008.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]}}}